GS Stock UPDATES Goldman Sachs Group (GS) 184.04 09/16/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Goldman Sachs Group (GS) 184.04 $GS

Virginia sues banks for $1.15 bil
at Investor's Business Daily - 1 hr 1 min ago
The state is suing 13 banks, including Citigroup (C), Morgan Stanley (MS), JPMorgan Chase (JPM) and Goldman Sachs (GS), claiming they "fraudulently misrepresented" residential mortgage-backed securities in sales to Virginia's retirement fund.

Skip the Alibaba IPO -- Buy These Bank Stocks Ahead of Earnings Instead
at The Street - Tue Sep 16, 12:39PM CDT
Everyone’s clamoring for the mother of all IPOs. But here's why bank stocks are a better bet.

Video: Priceline Plans Debt Offering After Big Acquisitions
at Investor's Business Daily - Tue Sep 16, 11:34AM CDT
Priceline Group Tuesday said that it plans to offersenior notes in an underwritten public offering, subject to market and other conditions. The Norwalk, Conn.-based online travel company says that it plans to use the proceeds for general corporate...

Jim Cramer Says Interest Rates Are Headed Higher
at The Street - Tue Sep 16, 11:11AM CDT
We'll get some net interest margin going.

Alibaba Ups IPO Price Band to $66-$68 on Robust Demand - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 7:29AM CDT
Alibaba Group Holding Ltd.'s amended filing with the U.S. Securities and Exchange Commission revealed that the company increased the price range of its pending Initial Public Offering (IPO) to $66-$68 from $60-$66 per share.

Is Goldman Sachs One of the Best Companies in America?
John Maxfield, The Motley Fool - Motley Fool - Mon Sep 15, 12:16PM CDT
In partnership with Glassdoor , our investment analysts are taking a closer look at some of the most popular companies in Glassdoor's career community. Goldman Sachs sets the standard for excellence both on Wall Street and throughout the ...

Will Health Care REIT's Share Offering Boost Liquidity? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 9:50AM CDT
Health Care REIT (HCN) is projected to reap around $988 million (or $1.1 billion, if underwriters' option is fully exercised) in proceeds from the recently declared common shares offering.

How Will Conversant (CNVR) Stock React Today To This Ratings Upgrade?
at The Street - Mon Sep 15, 9:44AM CDT
Goldman Sachs (GS) upgraded Conversant (CNVR) to 'neutral' from 'sell' with a price target of $31.

The Zacks Analyst Blog Highlights: Citigroup, BB&T, Goldman Sachs Group, Bank of America and JPMorgan Chase
PR Newswire - Mon Sep 15, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Citigroup Inc. (NYSE:C-Free Report), BB&T Corporation (NYSE:BBT-Free Report), Goldman Sachs Group, Inc. (NYSE:GS-Free Report), Bank of America Corp. (NYSE:BAC-Free Report) and JPMorgan Chase & Co. (NYSE:JPM-Free Report).

Why Cree (CREE) Stock Is Lower In Pre-Market Trading Today
at The Street - Mon Sep 15, 8:25AM CDT
Cree (CREE) stock is falling in pre-market trading following a ratings downgrade to 'neutral' from 'buy at Goldman Sachs (GS).

New Service, Chairman's Statement, Dividend, Joint Product Launch, and New Program - Research Reports on Visa, Goldman Sachs, AvalonBay, American Express and Regions
PR Newswire - Mon Sep 15, 8:20AM CDT
Today, Analysts Review released its research reports regarding Visa Inc. (NYSE: V), The Goldman Sachs Group Inc. (NYSE: GS), AvalonBay Communities Inc. (NYSE: AVB), American Express Company (NYSE: AXP) and Regions Financial Corp. (NYSE: RF). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6465-100free.

Charter closes on USD 3.5bn of term loans
M2 - Mon Sep 15, 12:21AM CDT
US broadband provider Charter Communications Inc (NASDAQ: CHTR) said that on September 12 its CCO Safari unrestricted subsidiary entered into a term loan G senior secured credit facility pursuant to the terms of the Charter Communications Operating LLC amended and resaid credit agreement, providing for USD 3.5bn of term loans.

Will HBO “Cut the Cord” and Snub Cable Providers
Jamal Carnette, The Motley Fool - Motley Fool - Sun Sep 14, 12:00PM CDT
Source: HBO On Wednesday, September 10, 2014, CNet reported that Jeff Bewkes, CEO of HBO's parent company Time Warner , turned heads at a Goldman Sachs investor conference in regards to access of its website, HBO Go. On the surface, there was...

'Fast Money' Recap: Rotating Into Underperforming Financial Stocks
at The Street - Sat Sep 13, 4:00AM CDT
The trading panel discussed Alibaba's IPO and how to invest ahead of the Federal Reserve meeting.

HSBC paying $550M to resolve mortgage bond claims
By MARCY GORDON - AP - Fri Sep 12, 4:56PM CDT
WASHINGTON (AP) — British bank HSBC has agreed to pay $550 million to resolve U.S. claims that it misled U.S. mortgage giants Fannie Mae and Freddie Mac about risky mortgage securities it sold them before the housing market collapsed in 2007.

Stocks Turn Ugly, Losses Widen; Ulta Beauty, Goldman Advance
at Investor's Business Daily - Fri Sep 12, 1:53PM CDT
Stocks sketched an ugly picture Friday as the indexes headed into the final hour unable to shake off the losses. The Nasdaq and the S&P 500 stumbled 0.6% and 0.7% respectively, while the small cap Russell 2000 lost 1.1%. Volume accelerated, moving...

Bank Stock Roundup: Citigroup, BB&T in Focus for Growth Strategies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 10:52AM CDT
While increased capital regulations are being planned for banks, restructuring and inorganic growth activities ruled the headlines.

Dow Jones (DJIA) Today: Goldman Sachs Group (GS) Higher
at The Street - Fri Sep 12, 10:00AM CDT
The Dow component leading the way higher looks to be Goldman Sachs Group (NYSE:GS), which is sporting a $1.88 gain (+1%) bringing the stock to $182.88.

Health Care REIT Boosts Liquidity; Guides 2H14 Buyouts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 9:50AM CDT
Health Care REIT (HCN) disclosed the common shares offering to strengthen its liquidity position and its projected acquisition pipeline for the second half of 2014.

'Fast Money' Recap: Protecting Yourself Before the Next Fed Meeting
at The Street - Fri Sep 12, 4:00AM CDT
The trading panel discussed whether the central bank will be more hawkish at next week's meeting.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 180

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 298

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 343

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 229

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading